{"id":"diclofenac-sodium-gel-1","safety":{"commonSideEffects":[{"rate":null,"effect":"Local skin irritation or rash at application site"},{"rate":null,"effect":"Photosensitivity reactions"},{"rate":null,"effect":"Pruritus"},{"rate":null,"effect":"Erythema"}]},"_chembl":null,"_dailymed":{"setId":"a133d18e-981d-43b7-bef1-7869f7c7d9a7","title":"DICLOFENAC SODIUM (DICLOFENAC SODIUM TOPICAL GEL, 1%) GEL [SPORTPHARM LLC]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"As a nonsteroidal anti-inflammatory drug (NSAID), diclofenac blocks COX-1 and COX-2 enzymes, which are responsible for producing prostaglandins that mediate inflammation, pain, and fever. When applied topically as a gel, it penetrates the skin to reach underlying tissues and joints, providing localized anti-inflammatory and analgesic effects with reduced systemic exposure compared to oral formulations.","oneSentence":"Diclofenac sodium inhibits cyclooxygenase (COX) enzymes to reduce prostaglandin synthesis, thereby decreasing inflammation and pain at the site of application.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:45:52.994Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Topical treatment of localized pain and inflammation in musculoskeletal conditions (e.g., osteoarthritis, rheumatoid arthritis, sprains, strains)"},{"name":"Post-traumatic inflammation and pain relief"}]},"trialDetails":[{"nctId":"NCT07475663","phase":"PHASE3","title":"Counterpain PXM Versus Diclofenac Versus Piroxicam","status":"COMPLETED","sponsor":"Taisho Pharmaceutical Indonesia","startDate":"2025-11-04","conditions":"Ankle Sprain, Back Pain, Osteoarthritis (OA) of the Knee","enrollment":180},{"nctId":"NCT07079969","phase":"PHASE2","title":"Effects of Photobiomodulation and Topical Diclofenac on Inflammation and Pain in Knee Osteoarthritis (EPIC-KO)","status":"NOT_YET_RECRUITING","sponsor":"University of Florida","startDate":"2026-04","conditions":"Knee Pain Chronic","enrollment":32},{"nctId":"NCT06379893","phase":"PHASE4","title":"A Real-World Evidence Study to Evaluate the Effects of Voltaren Use on Mobility and Quality of Life in Participants With Knee Osteoarthritis Pain","status":"COMPLETED","sponsor":"HALEON","startDate":"2024-04-25","conditions":"Pain","enrollment":196},{"nctId":"NCT06729073","phase":"PHASE1","title":"Comparison of Diclofenac Systemic Exposure From Two Different Products (AMZ001 and Diclofenac Diethylammonium 1.16% Gel) in Healthy Participants After Repeated Topical Administrations for 7 Days.","status":"COMPLETED","sponsor":"Amzell","startDate":"2024-11-29","conditions":"Healthy Volunteer","enrollment":34},{"nctId":"NCT07060976","phase":"NA","title":"To Check Dermatological Safety of Test Products by 24 Hours Patch Testing","status":"COMPLETED","sponsor":"Novamed Laboratories Pvt. Ltd.","startDate":"2025-07-21","conditions":"Healthy Participants","enrollment":26},{"nctId":"NCT07177560","phase":"","title":"Topical Diclofenac for Hand-Foot Syndrome Prevention in Colorectal and Gastric Cancer on Capecitabine (DICLO-HFS)","status":"COMPLETED","sponsor":"Gazi University","startDate":"2023-07-30","conditions":"Colorectal Cancer, Gastric Cancer (GC), Capecitabine","enrollment":151},{"nctId":"NCT05752526","phase":"PHASE1","title":"A Study of Diclofenac Gel in Women With Primary Dysmenorrhea","status":"COMPLETED","sponsor":"Daré Bioscience, Inc.","startDate":"2023-05-19","conditions":"Dysmenorrhea Primary","enrollment":42},{"nctId":"NCT05877027","phase":"NA","title":"Exercise vs. Topical Diclofenac vs. PRP","status":"COMPLETED","sponsor":"Istanbul University - Cerrahpasa","startDate":"2024-03-20","conditions":"Gonarthrosis","enrollment":82},{"nctId":"NCT06439251","phase":"PHASE1, PHASE2","title":"Effects of Mulligan Technique With or Without Diclofenac Phonophoresis on Patellofemoral Pain Syndrome.","status":"COMPLETED","sponsor":"University of Lahore","startDate":"2023-10-18","conditions":"Patellofemoral Pain Syndrome","enrollment":68},{"nctId":"NCT07101016","phase":"NA","title":"Effect of Local Use of Non-steroidal Anti-inflammatory Agent (Diclofenac Sodium) With and Without Hyaluronidase on Post-surgical Pain and Swelling","status":"NOT_YET_RECRUITING","sponsor":"Mariam Hesham Mahmoud Abdelfattah Eissa","startDate":"2025-08-01","conditions":"Root End Resection, Periapical Lesion, Single Rooted Teeth","enrollment":44},{"nctId":"NCT07043699","phase":"NA","title":"Effect of Phonophoresis Versus Iontophoresis in the Treatment of Perimenopausal Plantar Fasciitis","status":"COMPLETED","sponsor":"Cairo University","startDate":"2024-12-01","conditions":"Plantar Fasciitis","enrollment":42},{"nctId":"NCT05882812","phase":"PHASE2","title":"Sustained Acoustic Medicine (SAM) for Symptomatic Treatment of Knee Pain Related to Osteoarthritis","status":"COMPLETED","sponsor":"ZetrOZ, Inc.","startDate":"2023-06-03","conditions":"Osteo Arthritis Knee, Arthritis","enrollment":200},{"nctId":"NCT05050448","phase":"PHASE1, PHASE2","title":"Comparative Usability Evaluation of Sustained Acoustic Medicine (SAM) Devices and Topical Gel for OA Knee Pain","status":"COMPLETED","sponsor":"ZetrOZ, Inc.","startDate":"2021-08-01","conditions":"Knee Osteoarthritis","enrollment":60},{"nctId":"NCT05968482","phase":"PHASE1","title":"Bioavailability and Safety Study Comparing Two Dose Levels of AMZ001 and One Dose Level of Diclofenac Sodium 1% Gel in Healthy Participants","status":"COMPLETED","sponsor":"Amzell","startDate":"2023-07-11","conditions":"Healthy","enrollment":74},{"nctId":"NCT06574191","phase":"NA","title":"The Effects of Patient and Visit Characteristics on Health Outcomes in Knee Osteoarthritis","status":"RECRUITING","sponsor":"University of California, Davis","startDate":"2025-01-29","conditions":"Knee Osteoarthritis","enrollment":220},{"nctId":"NCT06864078","phase":"NA","title":"IUCD Insertion in Patients Delivered by Cesarean Section","status":"COMPLETED","sponsor":"Al-Azhar University","startDate":"2023-09-10","conditions":"IUD","enrollment":128},{"nctId":"NCT06510062","phase":"PHASE1","title":"Comparative Evaluation of Sustained Acoustic Medicine Device on Circulation","status":"COMPLETED","sponsor":"ZetrOZ, Inc.","startDate":"2024-07-22","conditions":"Measurement of Circulation on Anatomical Locations of the Body","enrollment":67},{"nctId":"NCT06257537","phase":"PHASE2","title":"Sustained Acoustic Medicine for Symptomatic Treatment of Knee Pain Related to Osteoarthritis","status":"RECRUITING","sponsor":"ZetrOZ, Inc.","startDate":"2024-10-01","conditions":"Osteo Arthritis Knee, Arthritis","enrollment":300},{"nctId":"NCT05883241","phase":"PHASE1","title":"Sustained Acoustic Medicine (SAM) for Symptomatic Treatment of Pain Related to Bone Fracture","status":"RECRUITING","sponsor":"ZetrOZ, Inc.","startDate":"2023-06-01","conditions":"Bone Fracture, Fresh Fracture","enrollment":90},{"nctId":"NCT05254574","phase":"PHASE1","title":"Sustained Acoustic Medicine for Osteoarthritis Pain","status":"RECRUITING","sponsor":"ZetrOZ, Inc.","startDate":"2022-02-14","conditions":"Osteoarthritis","enrollment":200},{"nctId":"NCT02406014","phase":"PHASE4","title":"Efficacy and Safety of Ingenol Mebutate Gel 0.015% Compared to Diclofenac Sodium Gel 3% in Subjects With Actinic Keratoses on the Face or Scalp","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2015-04","conditions":"Actinic Keratosis (AK)","enrollment":502},{"nctId":"NCT05387525","phase":"PHASE4","title":"A Study of Tirbanibulin Ointment and Diclofenac Sodium Gel for the Treatment of Adult Participants With Actinic Keratosis on the Face or Scalp","status":"ACTIVE_NOT_RECRUITING","sponsor":"Almirall, S.A.","startDate":"2022-10-24","conditions":"Keratosis, Actinic","enrollment":447},{"nctId":"NCT05312645","phase":"PHASE3","title":"Diclofenac Gel in the Treatment of Cervicogenic Headache","status":"WITHDRAWN","sponsor":"Loma Linda University","startDate":"2023-12","conditions":"Cervicogenic Headache","enrollment":""},{"nctId":"NCT05026320","phase":"PHASE2","title":"A Clinical Trial to Compare Safety and Effectiveness for Relieving Tenderness of 10% Naproxen Gel vs. a 2.32% Diclofenac Diethylamine Gel in the Treatment of Strains and Bruises of the Legs.","status":"COMPLETED","sponsor":"Bayer","startDate":"2021-08-08","conditions":"Soft Tissue Injury","enrollment":76},{"nctId":"NCT04611529","phase":"PHASE4","title":"Acute Low Back Pain. Topical Diclofenac and Oral Ibuprofen.","status":"COMPLETED","sponsor":"Montefiore Medical Center","startDate":"2021-03-02","conditions":"Low Back Pain","enrollment":198},{"nctId":"NCT06192420","phase":"PHASE3","title":"TRAUMED - a Clinical Trial in Acute Ankle Sprain","status":"COMPLETED","sponsor":"Biologische Heilmittel Heel GmbH","startDate":"2018-02-26","conditions":"Ankle Sprain","enrollment":809},{"nctId":"NCT06094361","phase":"NA","title":"\"IONTOPHORESIS vs. PHONOPHORESIS\" for Treatment of Subacromial Impingement Syndrome","status":"COMPLETED","sponsor":"Emre Şenocak","startDate":"2015-06-01","conditions":"Subacromial Impingement Syndrome","enrollment":43},{"nctId":"NCT05413096","phase":"EARLY_PHASE1","title":"Combination of Diclofenac Potassium and Propolis in the Therapy of Oral Aphthosis","status":"COMPLETED","sponsor":"Al-Azhar University","startDate":"2021-06-01","conditions":"Oral Mucositis, ORAS, Oral Infection","enrollment":100},{"nctId":"NCT04766996","phase":"PHASE4","title":"PROUD Study - Preventing Opioid Use Disorders","status":"TERMINATED","sponsor":"Emory University","startDate":"2021-05-17","conditions":"Anesthesia, Opioid Use","enrollment":57},{"nctId":"NCT05475639","phase":"NA","title":"Axillary Phonophoresis Versus Post Isometric Facilitation in the Treatment of Shoulder Adhesive Capsulitis","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2023-02-25","conditions":"Adhesive Capsulitis of Shoulder","enrollment":45},{"nctId":"NCT04592016","phase":"NA","title":"Evaluate the Ability of dOFM for BE Testing of Topically Applied Diclofenac Sodium Products in Healthy Subjects","status":"COMPLETED","sponsor":"Joanneum Research Forschungsgesellschaft mbH","startDate":"2020-10-08","conditions":"Healthy","enrollment":22},{"nctId":"NCT05434039","phase":"NA","title":"Diclofenac Phonophoresis Versus High Power Pain Threshold Ultrasound on Patients With Neck Pain","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2022-07-30","conditions":"Neck Pain","enrollment":60},{"nctId":"NCT04052620","phase":"PHASE3","title":"Voltaren Emulgel 2% Acute Ankle Sprain Non Inferiority Study","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2019-10-24","conditions":"Pain","enrollment":313},{"nctId":"NCT03172780","phase":"PHASE3","title":"A Bioequivalence Study Using Clinical Endpoint for Diclofenac Sodium Gel 1% in Osteoarthritis Knee\"","status":"COMPLETED","sponsor":"Mylan Pharmaceuticals Private Limited","startDate":"2017-05-24","conditions":"Osteoarthritis, Knee","enrollment":1220},{"nctId":"NCT01453179","phase":"PHASE4","title":"Long-term Effects of Imiquimod and Diclofenac in Actinic Keratoses (LEIDA 2)","status":"COMPLETED","sponsor":"MEDA Pharma GmbH & Co. KG","startDate":"2011-10","conditions":"Actinic Keratosis","enrollment":221},{"nctId":"NCT00777127","phase":"PHASE4","title":"Long-term Effects of Imiquimod and Diclofenac in Actinic Keratoses","status":"COMPLETED","sponsor":"MEDA Pharma GmbH & Co. KG","startDate":"2008-12","conditions":"Actinic Keratosis","enrollment":258},{"nctId":"NCT03528824","phase":"NA","title":"Fenugreek Wraps in Osteoarthritis of the Knee","status":"COMPLETED","sponsor":"Universität Duisburg-Essen","startDate":"2018-06-01","conditions":"Osteoarthritis, Knee","enrollment":81},{"nctId":"NCT03434197","phase":"PHASE3","title":"Safety and Efficacy of SFPP in Knee Osteoarthritis","status":"COMPLETED","sponsor":"Taisho Pharmaceutical Co., Ltd.","startDate":"2018-02-05","conditions":"Osteoarthritis Knee Pain","enrollment":313},{"nctId":"NCT02121002","phase":"PHASE3","title":"Study Comparing a Generic Diclofenac Sodium Topical Gel, 1% to Voltaren in the Treatment of Subjects With Osteoarthritis of the Knee","status":"COMPLETED","sponsor":"Amneal Pharmaceuticals, LLC","startDate":"2014-04","conditions":"Osteoarthritis","enrollment":1176},{"nctId":"NCT02913521","phase":"PHASE3","title":"Bioequivalence Study With Clinical Endpoint for Diclofenac Sodium Topical Gel 1%","status":"COMPLETED","sponsor":"Akorn, Inc.","startDate":"2015-06","conditions":"Osteoarthritis, Knee","enrollment":934},{"nctId":"NCT02666846","phase":"PHASE1","title":"Assess the Efficacy and Safety in Volunteers of DCF100, TIB200 and SPR300 vs. Placebo and Control(s) in a UV Pain Model","status":"COMPLETED","sponsor":"Futura Medical Developments Ltd.","startDate":"2015-03","conditions":"Pain","enrollment":60},{"nctId":"NCT04402047","phase":"NA","title":"Electroacupuncture vs Topical Diclofenac Sodium Gel for Patients With Hand Osteoarthritis","status":"UNKNOWN","sponsor":"Guang'anmen Hospital of China Academy of Chinese Medical Sciences","startDate":"2020-09-01","conditions":"Hand Osteoarthritis","enrollment":108},{"nctId":"NCT04341402","phase":"PHASE2","title":"Systemic Uptake of Diclofenac Sodium in Combination With Miconazole as Antifungal Nail Gel When Applied Daily With Monitoring of Hepatic and Renal Enzymes, and Serum Levels of Diclofenac 12 Hours After Application, and at 3 and 6 Months Study","status":"UNKNOWN","sponsor":"William N Handelman","startDate":"2020-05-01","conditions":"Tinea Unguium, Onychomycosis","enrollment":30},{"nctId":"NCT03497039","phase":"PHASE1","title":"A Study to Characterize Diclofenac's Plasma and Knee Exposure After Application of Diclofenac Gel to the Knee of Subjects With Osteoarthritis That Have a Scheduled Arthroplasty","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2018-07-19","conditions":"Pain","enrollment":47},{"nctId":"NCT04270968","phase":"NA","title":"Shock Wave Therapy On Cervical Pain Following Neck Dissection Surgery","status":"COMPLETED","sponsor":"Qassim University","startDate":"2018-11-03","conditions":"Pain, Cervical Pain","enrollment":46},{"nctId":"NCT03020368","phase":"NA","title":"Effectiveness and Safety of Breeded Leech for Symptomatic Primary Arthrosis of the First Carpometacarpal Joint","status":"TERMINATED","sponsor":"Charite University, Berlin, Germany","startDate":"2017-01","conditions":"Rhizarthrosis","enrollment":52},{"nctId":"NCT03831321","phase":"PHASE4","title":"The Effect of Preemptive Analgesia On The Comfort Of Patient and Doctor, in Cystoscopy","status":"UNKNOWN","sponsor":"Taha Uçar","startDate":"2018-12-11","conditions":"Bladder Cancer, Benign Prostate Hyperplasia, Hematuria","enrollment":144},{"nctId":"NCT02100670","phase":"PHASE3","title":"A Multicenter Efficacy Study of a Diclofenac+Menthol Gel in Subjects With Ankle Sprain","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2013-11-01","conditions":"Pain","enrollment":385},{"nctId":"NCT02169154","phase":"PHASE1","title":"A Safety Study to Investigate the Skin Irritancy Potential of Diclofenac-Menthol Gel","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2014-06-01","conditions":"Pain","enrollment":36},{"nctId":"NCT02201238","phase":"PHASE1","title":"Pharmacokinetics Study Comparing Topical Diclofenac/Menthol Gels With Voltaren Gel and Oral Diclofenac Sodium","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2014-10-01","conditions":"Pain","enrollment":18},{"nctId":"NCT02192203","phase":"PHASE1","title":"A Safety Study to Investigate the Skin Sensitization Potential of MFC51123","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2014-04-01","conditions":"Pain","enrollment":227},{"nctId":"NCT02596451","phase":"PHASE3","title":"To Study Generic Diclofenac Sodium Topical Gel 1% in the Treatment of Osteoarthritis of the Knee (Degenerative Joint Disease Presented as Joint Pain, Stiffness, Swelling and Restricted Motion).","status":"COMPLETED","sponsor":"Glenmark Pharmaceuticals Ltd. India","startDate":"2015-08","conditions":"Osteoarthritis","enrollment":1164},{"nctId":"NCT02290821","phase":"PHASE3","title":"Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Compared to Placebo in Subjects With Acute Blunt Trauma Injuries","status":"COMPLETED","sponsor":"Novartis","startDate":"2014-12","conditions":"Acute Blunt Soft Tissue Injuries/Contusions","enrollment":215},{"nctId":"NCT00601640","phase":"PHASE2","title":"Eflornithine and/or Diclofenac in Treating Patients With Sun-Damaged Skin","status":"COMPLETED","sponsor":"University of Arizona","startDate":"2007-01","conditions":"Other Benign Neoplasm of Skin, Unspecified","enrollment":184},{"nctId":"NCT02332057","phase":"PHASE2","title":"Diclofenac Plus Lidocaine Gel for Pain Relief During Intrauterine Device Insertion(IUD).","status":"COMPLETED","sponsor":"Cairo University","startDate":"2015-02","conditions":"Pain","enrollment":90},{"nctId":"NCT02271854","phase":"PHASE3","title":"A Within-subject Study to Evaluate the Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Compared to Placebo in Subjects Experiencing Delayed Onset Muscle Soreness","status":"COMPLETED","sponsor":"Novartis","startDate":"2014-10","conditions":"Muscle Soreness","enrollment":102},{"nctId":"NCT01967550","phase":"PHASE3","title":"Efficacy and Safety of Diclofenac DDEA 2.32 % in Patient Suffering From Knee Osteoarthritis (OA)","status":"COMPLETED","sponsor":"Novartis","startDate":"2013-10","conditions":"Osteoarthritis, Knee","enrollment":304},{"nctId":"NCT00171665","phase":"PHASE3","title":"Efficacy and Safety of Diclofenac Sodium Gel in Hand Osteoarthritis","status":"COMPLETED","sponsor":"Novartis","startDate":"2005-05","conditions":"Osteoarthritis","enrollment":360},{"nctId":"NCT01454791","phase":"PHASE4","title":"Diclofenac Sodium Topical Gel to Reduce Injection Site Discomfort in Patients Taking Glatiramer Acetate","status":"COMPLETED","sponsor":"Brown, Theodore R., M.D., MPH","startDate":"2011-01","conditions":"Multiple Sclerosis","enrollment":40},{"nctId":"NCT02087748","phase":"PHASE4","title":"An Investigator Initiated, Within-Subject, Proof of Concept Study to Assess the Efficacy and Safety of Voltaren Gel in Subjects With DOMS","status":"COMPLETED","sponsor":"Lotus Clinical Research, LLC","startDate":"2014-03","conditions":"Pain, Delayed Onset Muscle Soreness","enrollment":24},{"nctId":"NCT01202799","phase":"PHASE1","title":"Pharmacokinetics, Bioavailability and Safety of PENNSAID® Gel","status":"COMPLETED","sponsor":"Mallinckrodt","startDate":"2010-09","conditions":"Pain","enrollment":30},{"nctId":"NCT02068859","phase":"PHASE3","title":"Treatment of Knee Pain With Topical Diclofenac Cream 8% or Diclofenac Gel 1%","status":"UNKNOWN","sponsor":"FPR Specialty Pharmacy","startDate":"2014-01","conditions":"Knee Pain Chronic, Knee Injuries","enrollment":106},{"nctId":"NCT01812928","phase":"PHASE2","title":"Diclofenac Suppository to Control Pain During Flexible Cystoscopy","status":"COMPLETED","sponsor":"Aga Khan University","startDate":"2013-03","conditions":"Pain, Hematuria, Lower Urinary Tract Symptoms","enrollment":60},{"nctId":"NCT01272934","phase":"PHASE3","title":"Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Applied Four Times Daily in Subjects With Acute Ankle Sprain","status":"COMPLETED","sponsor":"Novartis","startDate":"2011-01","conditions":"Acute Ankle Sprain","enrollment":205},{"nctId":"NCT01272947","phase":"PHASE3","title":"Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Applied Four Times Daily in Subjects With Acute Blunt Trauma Injuries","status":"COMPLETED","sponsor":"Novartis","startDate":"2011-01","conditions":"Acute Blunt Soft Tissue Injuries/Contusions","enrollment":204},{"nctId":"NCT01255423","phase":"PHASE3","title":"Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Applied 4 Times Daily in Subjects With Acute Ankle Sprain","status":"COMPLETED","sponsor":"Novartis","startDate":"2010-11","conditions":"Ankle Sprain","enrollment":206},{"nctId":"NCT01456611","phase":"PHASE3","title":"Evaluation of Clinical Endpoints of Two Diclofenac Sodium Gel 1%","status":"COMPLETED","sponsor":"Anchen Pharmaceuticals, Inc","startDate":"2011-09","conditions":"Osteo Arthritis of the Knee","enrollment":749},{"nctId":"NCT00171691","phase":"PHASE3","title":"Safety of Diclofenac Sodium Gel in Knee Osteoarthritis","status":"COMPLETED","sponsor":"Novartis","startDate":"2004-10","conditions":"Osteoarthritis","enrollment":450},{"nctId":"NCT00171678","phase":"PHASE3","title":"Efficacy and Safety of Diclofenac Sodium Gel in Knee Osteoarthritis","status":"COMPLETED","sponsor":"Novartis","startDate":"2004-10","conditions":"Osteearthritis","enrollment":480},{"nctId":"NCT00171626","phase":"PHASE3","title":"Efficacy and Safety of Diclofenac Sodium Gel in Knee Osteoarthritis","status":"COMPLETED","sponsor":"Novartis","startDate":"2004-08","conditions":"Osteoarthritis","enrollment":480},{"nctId":"NCT00573768","phase":"PHASE2","title":"Efficacy and Safety of Diclofenac Diethylamine 2.32% Gel in Patients With Acute Ankle Sprain","status":"COMPLETED","sponsor":"Novartis","startDate":"2007-11","conditions":"Ankle Sprain","enrollment":271},{"nctId":"NCT00426621","phase":"PHASE3","title":"Efficacy and Safety of Diclofenac Sodium Gel (DSG) in Knee Osteoarthritis","status":"COMPLETED","sponsor":"Novartis","startDate":"2006-11","conditions":"Osteoarthritis of the Knee","enrollment":420},{"nctId":"NCT00377806","phase":"PHASE4","title":"Topical Diclofenac Gel in Patients With Superficial Inflammation of the Veins","status":"COMPLETED","sponsor":"Novartis","startDate":"2003-01","conditions":"Superficial Thrombophlebitis of the Upper Limb","enrollment":200},{"nctId":"NCT00441051","phase":"PHASE3","title":"Efficacy and Safety of Diclofenac Sodium (0.1%) Gel in Patients With UV Induced Painful Sunburn","status":"COMPLETED","sponsor":"Novartis","startDate":"2006-11","conditions":"Sunburn","enrollment":45},{"nctId":"NCT00171652","phase":"PHASE3","title":"Efficacy and Safety of Diclofenac Sodium Gel in Hand Osteoarthritis","status":"COMPLETED","sponsor":"Novartis","startDate":"2005-05","conditions":"Osteoarthritis","enrollment":360}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":5,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Diclofenac Sodium gel, 1%","genericName":"Diclofenac Sodium gel, 1%","companyName":"Glenmark Pharmaceuticals Ltd. India","companyId":"glenmark-pharmaceuticals-ltd-india","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Diclofenac sodium inhibits cyclooxygenase (COX) enzymes to reduce prostaglandin synthesis, thereby decreasing inflammation and pain at the site of application. Used for Topical treatment of localized pain and inflammation in musculoskeletal conditions (e.g., osteoarthritis, rheumatoid arthritis, sprains, strains), Post-traumatic inflammation and pain relief.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}